Moderna and Merck release phase 3 melanoma vaccine results after leak
Moderna and Merck released detailed phase 3 results for their personalized mRNA melanoma vaccine, intismeran autogene, after partial data leaked online earlier that day. In roughly 1,100 patients whose tumors had been removed by surgery, the vaccine plus…
